INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European...
AKANDA's wholly owned subsidiary Bophelo Bioscience, which operates the company’s key cultivation facility in Lesotho, has been taken into liquidation by the country’s high...
It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making progress on cannabis liberalisation.
Germany's...
AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable week compared to their...
European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.
Mid-week...
AKANDA Corp has become the latest British cannabis company to go public after it launched on the NASDAQ Stock Exchange this week, seeing its stock soar some 350% above its listing price.
At Akanda, Dr. Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.